Skip to content

Acquisitions at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$405.01M
Opko Health logo
Opko HealthOPK
$0-100%
Agilent Technologies logo
Agilent TechnologiesA
$0
Azenta logo
AzentaAZTA
$0
PDF Solutions logo
PDF SolutionsPDFS
$0-100%
IQVIA logo
IQVIAIQV
$37M-72.4%

Other financials

Income statement

See full
Revenue$24.3M+8.3%
Gross profit$16.1M+23.0%
Operating income$5.6M+108%
Net income$4.5M+47.5%
EPS (diluted)$0.22+46.7%

Balance sheet

See full
Cash & equivalents$25.7M+134%
Total debt$508.0K-36.2%
Total equity$133.8M-29.4%
Total assets$146.5M-27.3%

Cash flow

See full
Operating cash flow$6.4M+13.1%
CapEx$46.0K-30.3%
Free cash flow$6.4M+13.6%

Valuation

See full
Market cap$366.73M+5.2%
Enterprise value$341.51M+6.0%
P/S4.6×+0.2×

Profitability

See full
Gross margin62%+6.7pp
Operating margin-84.3%
Net margin-78%-87.2pp
FCF margin29.5%+14.9pp

Returns & leverage

See full
Return on equity-38.8%-42.8pp
Debt / equity0.0×
Current ratio5.5×+1.1×

Where this comes from

Reported directly by Simulations Plus in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates.

The official record: Simulations Plus’s 10-Q, filed January 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Simulations Plus's acquisitions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Simulations Plus's acquisitions?
Simulations Plus (SLP) reported acquisitions of $11K in Q3 2025.
How has Simulations Plus's acquisitions changed year-over-year?
Simulations Plus's acquisitions decreased by 94.1% year-over-year, from $186K to $11K.
What does acquisitions mean?
Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.